These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25761965)

  • 1. Multivariate longitudinal data analysis with mixed effects hidden Markov models.
    Raffa JD; Dubin JA
    Biometrics; 2015 Sep; 71(3):821-31. PubMed ID: 25761965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of individual long-term outcomes in smoking cessation trials using frailty models.
    Li Y; Wileyto EP; Heitjan DF
    Biometrics; 2011 Dec; 67(4):1321-9. PubMed ID: 21401566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent mixed Markov modelling of smoking transitions using Monte Carlo bootstrapping.
    Mannan HR; Koval JJ
    Stat Methods Med Res; 2003 Mar; 12(2):125-46. PubMed ID: 12665207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values.
    Li J; Yang X; Wu Y; Shoptaw S
    Stat Med; 2007 May; 26(12):2519-32. PubMed ID: 17106918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidden Markov latent variable models with multivariate longitudinal data.
    Song X; Xia Y; Zhu H
    Biometrics; 2017 Mar; 73(1):313-323. PubMed ID: 27148857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hidden Markov model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified.
    Benoit JS; Chan W; Luo S; Yeh HW; Doody R
    Stat Med; 2016 Apr; 35(9):1549-57. PubMed ID: 26782946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian restoration of a hidden Markov chain with applications to DNA sequencing.
    Churchill GA; Lazareva B
    J Comput Biol; 1999; 6(2):261-77. PubMed ID: 10421527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of neighbourhood disadvantage on smoking cessation and its contribution to inequalities in smoking status.
    Turrell G; Hewitt BA; Miller SA
    Drug Alcohol Rev; 2012 Jul; 31(5):645-52. PubMed ID: 22507105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of the risk of smoking-induced lung cancer: a compartmental hidden Markov model for longitudinal analysis.
    Chadeau-Hyam M; Tubert-Bitter P; Guihenneuc-Jouyaux C; Campanella G; Richardson S; Vermeulen R; De Iorio M; Galea S; Vineis P
    Epidemiology; 2014 Jan; 25(1):28-34. PubMed ID: 24240650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint Hidden Markov Model for Longitudinal and Time-to-Event Data with Latent Variables.
    Zhou X; Kang K; Kwok T; Song X
    Multivariate Behav Res; 2022; 57(2-3):441-457. PubMed ID: 33410715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian inference for smoking cessation with a latent cure state.
    Luo S; Crainiceanu CM; Louis TA; Chatterjee N
    Biometrics; 2009 Sep; 65(3):970-8. PubMed ID: 19173701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markov transition models for binary repeated measures with ignorable and nonignorable missing values.
    Xiaowei Yang ; Shoptaw S; Kun Nie ; Juanmei Liu ; Belin TR
    Stat Methods Med Res; 2007 Aug; 16(4):347-64. PubMed ID: 17715161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized linear mixed hidden semi-Markov models in longitudinal settings: A Bayesian approach.
    Haji-Maghsoudi S; Bulla J; Sadeghifar M; Roshanaei G; Mahjub H
    Stat Med; 2021 May; 40(10):2373-2388. PubMed ID: 33588516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A discrete time event-history approach to informative drop-out in mixed latent Markov models with covariates.
    Bartolucci F; Farcomeni A
    Biometrics; 2015 Mar; 71(1):80-89. PubMed ID: 25227970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian quantile nonhomogeneous hidden Markov models.
    Liu H; Song X; Tang Y; Zhang B
    Stat Methods Med Res; 2021 Jan; 30(1):112-128. PubMed ID: 32726188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal model for magnetic resonance imaging lesion count data in multiple sclerosis patients.
    MacKay Altman R; Petkau AJ; Vrecko D; Smith A
    Stat Med; 2012 Feb; 31(5):449-69. PubMed ID: 21964585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
    Park ES; Symanski E; Han D; Spiegelman C
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of panel data under hidden mover-stayer models.
    Yi GY; He W; He F
    Stat Med; 2017 Sep; 36(20):3231-3243. PubMed ID: 28766830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitting semiparametric random effects models to large data sets.
    Pennell ML; Dunson DB
    Biostatistics; 2007 Oct; 8(4):821-34. PubMed ID: 17429104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.